1. A novel flow cytometric assay for detection of residual disease in patients with B‐lymphoblastic leukemia/lymphoma post anti‐CD19 therapy. Issue 1 (23rd September 2016) Authors: Cherian, Sindhu; Miller, Valerie; McCullouch, Vivian; Dougherty, Katy; Fromm, Jonathan R.; Wood, Brent L. Journal: Cytometry Issue: Volume 94:Issue 1(2018) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A novel flow cytometric assay for detection of residual disease in patients with B‐lymphoblastic leukemia/lymphoma post anti‐CD19 therapy. Issue 1 (23rd September 2016) Authors: Cherian, Sindhu; Miller, Valerie; McCullouch, Vivian; Dougherty, Katy; Fromm, Jonathan R.; Wood, Brent L. Journal: Cytometry Issue: Volume 94:Issue 1(2018) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis. Issue 4 (11th December 2015) Authors: Cherian, Sindhu; McCullouch, Vivian; Miller, Valerie; Dougherty, Katy; Fromm, Jonathan R.; Wood, Brent L. Journal: Cytometry Issue: Volume 90:Issue 4(2016) Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗